Compliance news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
Transparency Initiatives Spread as Companies Acknowledge Rising Drug Costs More than a dozen states are considering drug price transparency bills — most recently in California, where a state senate committee voted to advance legislation requiring drugmakers to disclose operating costs. Read More
Drugmakers Request Revisions to Draft Guidance on Sharing Information with Payors Allergan questioned the draft guidance’s recommendations on disclosure of HCEI to payors. Read More
FDA’s Off-Label Communications Guidance Needs More Clarity, Industry Says The draft guidance is also overly vague in its distinction between scientific and promotional communication. Read More
Automation of Process Control within the Pharmaceutical Industry While most pharmaceutical businesses have adopted process automation in one format or another, the technology has evolved considerably over the past few years, leading to improvements in design, efficiency and reliability. One of the major drivers for businesses to increase levels of automation is legislation, but the need to compete in the market place and reduce ... Read More